Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling

被引:22
作者
Decruyenaere, M
Evers-Kiebooms, G
Denayer, L
Welkenhuysen, M
Claes, E
Legius, E
Demyttenaere, K
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Psychiat, Louvain, Belgium
关键词
hereditary breast and ovarian cancer; BRCA1; BRCA2; predictive testing; genetic counselling; psychological aspects;
D O I
10.1038/sj.ejhg.5200438
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the identification of two breast-ovarian cancer susceptibility genes (BRCA 1/2), predictive testing for hereditary breast/ovarian cancer (HBOC) has been available. Given the complexity and uncertainties of HBOC and the potential impact of predictive testing on psychological well-being, we offer the test applicants a combination of information-oriented and psychological counselling. In this paper, we describe the multidisciplinary approach for predictive testing for HBOC as a clinical service in Leuven, hereby focusing on psychological and decision counselling practice. Attention is paid to the theoretical framework used for pre-test psychological counselling in Leuven. We discuss three important interacting dimensions of psychological counselling: individual emotional support, decision counselling and support of the family communication process. Decision counselling consists of an evaluation of the cognitive and the emotional processing of the information given and strategies and resources for coping. This serves as a starting point to facilitate free informed decision making. Scenario development is used as a decision aid.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 65 条
[1]  
*ADV COMM GEN TEST, 1998, GEN TEST LAT DIS
[2]  
*AM CANC SOC, 1998, CANC FACTS FIG 1998, P4
[3]  
[Anonymous], N CAN I MONOGR
[4]  
Benkendorf JL, 1997, AM J MED GENET, V73, P296, DOI 10.1002/(SICI)1096-8628(19971219)73:3<296::AID-AJMG13>3.0.CO
[5]  
2-E
[6]   GENETIC-COUNSELING FOR FAMILIES WITH INHERITED SUSCEPTIBILITY TO BREAST AND OVARIAN-CANCER [J].
BIESECKER, BB ;
BOEHNKE, M ;
CALZONE, K ;
MARKEL, DS ;
GARBER, JE ;
COLLINS, FS ;
WEBER, BL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (15) :1970-1974
[7]   BRCA1 and BRCA2:: From molecular genetics to clinical medicine [J].
Blackwood, MA ;
Weber, BL .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1969-1977
[8]  
BODDINGTON P, 1994, GENETIC COUNSELLING, P223
[9]   A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing - Commentary [J].
Botkin, JR ;
Croyle, RT ;
Smith, KR ;
Baty, BJ ;
Lerman, C ;
Goldgar, DE ;
Ward, JM ;
Flick, BJ ;
Nash, JE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) :872-882
[10]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003